Liposomes for the co-delivery of honokiol and disulfiram/copper complex were developed to explore anti-GBM therapy via the mTOR regulatory pathway to remodel tumor metabolism and the tumor immune microenvironment. The gene discussed is MTOR; the disease is glioblastoma.